Amgen Inc (AMGN)
299.55
-11.74
(-3.77%)
USD |
NASDAQ |
May 06, 16:00
300.50
+0.95
(+0.32%)
Pre-Market: 09:12
Amgen Total Long Term Debt (Quarterly): 64.02B for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 64.02B |
December 31, 2023 | 64.61B |
September 30, 2023 | 60.47B |
June 30, 2023 | 61.54B |
March 31, 2023 | 61.60B |
December 31, 2022 | 38.94B |
September 30, 2022 | 38.70B |
June 30, 2022 | 36.52B |
March 31, 2022 | 36.85B |
December 31, 2021 | 33.31B |
September 30, 2021 | 37.58B |
June 30, 2021 | 32.78B |
March 31, 2021 | 32.68B |
December 31, 2020 | 32.99B |
September 30, 2020 | 34.29B |
June 30, 2020 | 34.22B |
March 31, 2020 | 31.85B |
December 31, 2019 | 29.90B |
September 30, 2019 | 29.79B |
June 30, 2019 | 30.61B |
March 31, 2019 | 33.02B |
December 31, 2018 | 33.93B |
September 30, 2018 | 34.43B |
June 30, 2018 | 34.50B |
March 31, 2018 | 35.54B |
Date | Value |
---|---|
December 31, 2017 | 35.34B |
September 30, 2017 | 35.78B |
June 30, 2017 | 35.06B |
March 31, 2017 | 34.09B |
December 31, 2016 | 34.60B |
September 30, 2016 | 35.32B |
June 30, 2016 | 33.22B |
March 31, 2016 | 34.31B |
December 31, 2015 | 31.43B |
September 30, 2015 | 31.76B |
June 30, 2015 | 31.95B |
March 31, 2015 | 30.34B |
December 31, 2014 | 30.72B |
September 30, 2014 | 32.98B |
June 30, 2014 | 33.33B |
March 31, 2014 | 32.02B |
December 31, 2013 | 32.13B |
September 30, 2013 | 27.19B |
June 30, 2013 | 23.92B |
March 31, 2013 | 23.89B |
December 31, 2012 | 26.53B |
September 30, 2012 | 26.48B |
June 30, 2012 | 24.38B |
March 31, 2012 | 21.41B |
December 31, 2011 | 21.43B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
29.79B
Minimum
Sep 2019
64.61B
Maximum
Dec 2023
41.16B
Average
35.40B
Median
Total Long Term Debt (Quarterly) Benchmarks
Gilead Sciences Inc | 0.00 |
Johnson & Johnson | 33.63B |
Eli Lilly and Co | 26.21B |
Merck & Co Inc | 34.22B |
Vertex Pharmaceuticals Inc | 0.00 |